Prostaglandin and thromboxane mediation of cardiopulmonary failure.
D000818:Animals; D001095:Arachidonic Acids / Q000096:biosynthesis; D002302:Cardiac Output / Q000187:drug effects; D002462:Cell Membrane / Q000378:metabolism; D002463:Cell Membrane Permeability; D004285:Dogs; D005342:Fibrinolysis / Q000187:drug effects; D006801:Humans; D007213:Indomethacin / Q000494:pharmacology; D007962:Leukocytes / Q000187:drug effects; D008168:Lung / Q000378:metabolism / Q000503:physiopathology; D010960:Plasminogen Activators / Q000378:metabolism; D010974:Platelet Aggregation / Q000187:drug effects; D011453:Prostaglandins / Q000096:biosynthesis / Q000502:physiology*; D011654:Pulmonary Edema / Q000503:physiopathology; D011655:Pulmonary Embolism / Q000503:physiopathology; D051381:Rats; D012121:Respiration, Artificial; D012131:Respiratory Insufficiency / Q000503:physiopathology*; D013931:Thromboxanes / Q000096:biosynthesis / Q000502:physiology*; D013997:Time Factors
D001095:Arachidonic Acids; D011453:Prostaglandins; D013931:Thromboxanes; D010960:Plasminogen Activators; D007213:Indomethacin